ARCHIVES

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001

In Brief: Patterns Of care Study Leads “Part Tie” Radiotherapists To Drop Out, Sheline Says

July 22, 1977

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

In Brief: Bogardus Heads ASTRO, Million President Elect; Woods Named Chief of NIC Contracts Review

October 27, 1989